HMGB2 Deficiency Mitigates Abdominal Aortic Aneurysm by Suppressing Ang-II-Caused Ferroptosis and Inflammation via

Hao Wu1, Legao Chen1, Kaiping Lu1

  • 1Department of Vascular Surgery, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, 158 Shangtang Road, Hangzhou, Zhejiang, China.

Mediators of Inflammation
|December 27, 2023
PubMed
Abstract

Insights

High mobility group box 2 (HMGB2) regulates ferroptosis and inflammation in abdominal aortic aneurysm (AAA). Inhibiting HMGB2 protects against AAA by modulating ferroptosis and inflammation via NF-κβ signaling.

Area of Science:

  • Biomedical research
  • Cellular biology
  • Pathology

Background:

  • Ferroptosis, a novel form of cell death, is implicated in various diseases.
  • Abdominal aortic aneurysm (AAA) pathogenesis involves complex cellular mechanisms.
  • This study investigates the role of High-mobility group box 2 (HMGB2) in regulating ferroptosis and inflammation within AAA.

Purpose of the Study:

  • To elucidate the mechanism by which HMGB2 influences ferroptosis and inflammation in AAA.
  • To determine the therapeutic potential of targeting HMGB2 in AAA treatment.

Main Methods:

  • Quantitative polymerase chain reaction and western blotting were used to measure HMGB2 expression.
  • Cell viability, apoptosis, reactive oxygen species (ROS) generation, and Fe2+ levels were assessed.
  • Ferroptosis markers (ACSL4, COX2, GPX4, FTH1) and NF-κβ signaling pathway activation were analyzed.
  • An in vivo mouse model of AAA was utilized to validate findings.

Main Results:

  • HMGB2 levels were elevated in Angiotensin II (Ang-II)-treated VSMCs and in an AAA mouse model.
  • HMGB2 depletion enhanced VSMC viability and reduced apoptosis.
  • Silencing HMGB2 decreased ROS production and attenuated Ang-II-induced VSMC ferroptosis.
  • HMGB2 inhibition reduced Fe2+ levels and altered ferroptosis-related protein expression (decreased ACSL4/COX2, increased GPX4/FTH1).
  • HMGB2 depletion inactivated the NF-κβ signaling pathway in VSMCs.

Conclusions:

  • HMGB2 inhibition mitigates ferroptosis and inflammation, offering protection against AAA.
  • The protective effects are mediated through the NF-κβ signaling pathway.
  • HMGB2 represents a potential therapeutic target for managing AAA.